MannKind Corp. (MNKD)
5.905
0.00 (0.00%)
USD |
NASDAQ |
Feb 10, 12:46
MannKind Shareholders Equity (Quarterly) : -44.55M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| Keros Therapeutics, Inc. | 703.58M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.64M |
| Total Liabilities (Quarterly) | 539.19M |
| Debt to Equity Ratio | -5.072 |
| Current Ratio | 3.288 |
| Net Debt Paydown Yield | 1.36% |